AbstractProduction of E1-deleted adenovirus (rAd) vectors requires complementation by E1A and E1B functions provided by the production cell line. The two cell lines most commonly used for production of rAd vectors, 293 and Per.C6, were derived from human primary cells and contain contiguous E1A and E1B sequences from the Ad genome. As an alternative system, we tested complementation of rAd vectors using sequential transfection of individual E1A and E1B expression cassettes into A549 human lung tumor cells, which support highly efficient replication of wild type adenovirus. We found that E1A function could be complemented in A549 cells by the mutant E1Adl01/07, and that E1B function could be provided in such cells using only the 55K E1B gene...
In vivo gene transfer of recombinant E1-deficient adenoviruses results in early and late viral gene ...
Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for ...
Until recently, adenovirus (Ad)-mediated gene therapy was almost exclusively based on human Ad type ...
AbstractProduction of E1-deleted adenovirus (rAd) vectors requires complementation by E1A and E1B fu...
E1-deleted adenovirus vectors (AdV) are important gene transfer vehicles for gene therapy and vaccin...
AbstractStrategies that enable E1-defective recombinant adenoviruses to selectively undergo replicat...
cell that expresses adenovirus E1 gene; Ad, adenovirus; m.u., map unit; m.o.i, multiplicity of infec...
A novel recombinant adenovirus vector, Av3nBg, was constructed with deletions in adenovirus E1, E2a,...
Most adenovirus (Ad) vectors are E1 gene deleted replication defective (RD-Ad) vectors that deliver ...
Purpose: To overcome the limitations of cancer gene therapy using replication-incom- petent adenovir...
AbstractReplication competent adenovirus (RC-Ad) vectors mediate robust transgene expression by virt...
Genetically modified adenoviruses (Ads) make attractive vectors for the delivery of exogenous DNA to...
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced i...
Replication-deficient human adenovirus type 5 (Ad5) can be produced to high titers in complementing ...
AbstractAdenoviral vectors have been used in gene therapy and for vaccination. The major concerns wi...
In vivo gene transfer of recombinant E1-deficient adenoviruses results in early and late viral gene ...
Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for ...
Until recently, adenovirus (Ad)-mediated gene therapy was almost exclusively based on human Ad type ...
AbstractProduction of E1-deleted adenovirus (rAd) vectors requires complementation by E1A and E1B fu...
E1-deleted adenovirus vectors (AdV) are important gene transfer vehicles for gene therapy and vaccin...
AbstractStrategies that enable E1-defective recombinant adenoviruses to selectively undergo replicat...
cell that expresses adenovirus E1 gene; Ad, adenovirus; m.u., map unit; m.o.i, multiplicity of infec...
A novel recombinant adenovirus vector, Av3nBg, was constructed with deletions in adenovirus E1, E2a,...
Most adenovirus (Ad) vectors are E1 gene deleted replication defective (RD-Ad) vectors that deliver ...
Purpose: To overcome the limitations of cancer gene therapy using replication-incom- petent adenovir...
AbstractReplication competent adenovirus (RC-Ad) vectors mediate robust transgene expression by virt...
Genetically modified adenoviruses (Ads) make attractive vectors for the delivery of exogenous DNA to...
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced i...
Replication-deficient human adenovirus type 5 (Ad5) can be produced to high titers in complementing ...
AbstractAdenoviral vectors have been used in gene therapy and for vaccination. The major concerns wi...
In vivo gene transfer of recombinant E1-deficient adenoviruses results in early and late viral gene ...
Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for ...
Until recently, adenovirus (Ad)-mediated gene therapy was almost exclusively based on human Ad type ...